Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,210,695
-
Share change
-
-365,150
-
Total reported value
-
$79,698,781
-
Put/Call ratio
-
118%
-
Price per share
-
$7.11
-
Number of holders
-
73
-
Value change
-
-$935,004
-
Number of buys
-
31
-
Number of sells
-
41
Institutional Holders of RECRO PHARMA INC - COM (SCTL) as of Q3 2018
As of 30 Sep 2018,
RECRO PHARMA INC - COM (SCTL) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,210,695 shares.
The largest 10 holders included
Broadfin Capital, LLC, Newtyn Management, LLC, BlackRock Inc., Alyeska Investment Group, L.P., Vanguard Group Inc, RENAISSANCE TECHNOLOGIES LLC, Engine Capital Management, LP, MANUFACTURERS LIFE INSURANCE COMPANY, THE, ACADIAN ASSET MANAGEMENT LLC, and ESSEX INVESTMENT MANAGEMENT CO LLC.
This page lists
73
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.